← Back to Search

Cognitive Behavioral Therapy for Cervical Spine Disease

N/A
Waitlist Available
Led By Peter Passias, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether cognitive-behavioral therapy can help improve outcomes for people undergoing surgery for cervical degenerative disease.

Who is the study for?
This trial is for adults with cervical disc herniation, spinal stenosis, or degenerative diseases needing spine surgery. They must have neck and arm symptoms, understand English, and be reachable by phone. Excluded are those with recent spine surgeries, other medical conditions causing neck pain, severe psychiatric issues or substance dependency.
What is being tested?
The study tests if Cognitive Behavioral Therapy (CBT) can improve outcomes in patients with psychological distress undergoing cervical spine surgery. It compares CBT to a sham treatment in two groups of 20 patients each who are randomly assigned.
What are the potential side effects?
Since the interventions involve therapy rather than medication, side effects may include discomfort during sessions or emotional distress due to discussing personal issues but no physical side effects like those from drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Distress and Risk Assessment Method (DRAM)
Outcome Expectation question (OEQ)
Pain Catastrophizing Scale (PCS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: CBTActive Control1 Intervention
All patients at risk will be stratified by risk rating and randomly assigned to 2 groups; sham treatment (N=20) or CBT (N=20).
Group II: Sham TreatmentActive Control1 Intervention
All patients at risk will be stratified by risk rating and randomly assigned to 2 groups; sham treatment (N=20) or CBT (N=20).
Group III: Comparison GroupActive Control1 Intervention
Patients with a zero risk score will serve as a comparison group (N=20).

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
856,029 Total Patients Enrolled
Peter Passias, MDPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
137 Total Patients Enrolled

Media Library

CBT Clinical Trial Eligibility Overview. Trial Name: NCT03183713 — N/A
Psychological Disability Research Study Groups: CBT, Sham Treatment, Comparison Group
Psychological Disability Clinical Trial 2023: CBT Highlights & Side Effects. Trial Name: NCT03183713 — N/A
CBT 2023 Treatment Timeline for Medical Study. Trial Name: NCT03183713 — N/A
~6 spots leftby Jan 2026